These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 22166808

  • 1. Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells.
    Ebert R, Zeck S, Meissner-Weigl J, Klotz B, Rachner TD, Benad P, Klein-Hitpass L, Rudert M, Hofbauer LC, Jakob F.
    Bone; 2012 Mar; 50(3):723-32. PubMed ID: 22166808
    [Abstract] [Full Text] [Related]

  • 2. Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells.
    Ebert R, Meissner-Weigl J, Zeck S, Määttä J, Auriola S, Coimbra de Sousa S, Mentrup B, Graser S, Rachner TD, Hofbauer LC, Jakob F.
    Mol Cancer; 2014 Dec 11; 13():265. PubMed ID: 25496233
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y, Varol U, Atmaca H, Kisim A, Sezgin C, Karabulut B, Uzunoglu S, Uslu R, Karaca B.
    BJU Int; 2012 Dec 11; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [Abstract] [Full Text] [Related]

  • 6. The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.
    Fragni M, Bonini SA, Bettinsoli P, Bodei S, Generali D, Bottini A, Spano PF, Memo M, Sigala S.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 May 11; 389(5):529-38. PubMed ID: 26905520
    [Abstract] [Full Text] [Related]

  • 7. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
    Jagdev SP, Coleman RE, Shipman CM, Rostami-H A, Croucher PI.
    Br J Cancer; 2001 Apr 20; 84(8):1126-34. PubMed ID: 11308265
    [Abstract] [Full Text] [Related]

  • 8. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation.
    Ebert R, Zeck S, Krug R, Meissner-Weigl J, Schneider D, Seefried L, Eulert J, Jakob F.
    Bone; 2009 May 20; 44(5):858-64. PubMed ID: 19442618
    [Abstract] [Full Text] [Related]

  • 9. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM, Senaratne SG, Clarke IA, Kirby RS, Colston KW.
    J Urol; 2003 Jul 20; 170(1):246-52. PubMed ID: 12796698
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
    Qiao H, Wang TY, Yan W, Qin A, Fan QM, Han XG, Wang YG, Tang TT.
    Acta Pharmacol Sin; 2015 Sep 20; 36(9):1085-98. PubMed ID: 26235741
    [Abstract] [Full Text] [Related]

  • 12. Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.
    Gschwantler-Kaulich D, Weingartshofer S, Grunt TW, Mairhofer M, Tan Y, Gamper J, Singer CF.
    PLoS One; 2017 Sep 20; 12(9):e0185566. PubMed ID: 28945801
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
    Surmeli Z, Gursoy P, Erdogan AP, Bozkurt E, Atmaca H, Uzunoglu S, Sezgin C, Şanlı UA, Uslu R, Karaca B.
    Tumour Biol; 2016 Mar 20; 37(3):3665-73. PubMed ID: 26462835
    [Abstract] [Full Text] [Related]

  • 17. Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.
    Räikkönen J, Crockett JC, Rogers MJ, Mönkkönen H, Auriola S, Mönkkönen J.
    Br J Pharmacol; 2009 Jun 20; 157(3):427-35. PubMed ID: 19371349
    [Abstract] [Full Text] [Related]

  • 18. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V, Gehrau RC, Bocco JL.
    IUBMB Life; 2010 Dec 20; 62(12):896-905. PubMed ID: 21154818
    [Abstract] [Full Text] [Related]

  • 19. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E, Linker-Israeli M, Said J, Umiel T, de Vos S, Shintaku IP, Heber D, Binderup L, Uskokovic M, Koeffler HP.
    Cancer Res; 1995 Jul 01; 55(13):2822-30. PubMed ID: 7796409
    [Abstract] [Full Text] [Related]

  • 20. Zoledronic acid-induced IPP/ApppI production in vivo.
    Mönkkönen H, Ottewell PD, Kuokkanen J, Mönkkönen J, Auriola S, Holen I.
    Life Sci; 2007 Sep 08; 81(13):1066-70. PubMed ID: 17850825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.